Price increases are the biggest driver of rising emergency room visit costs across the U.S., according to research led by the Center for Health and Biosciences' Vivian Ho and Sasathorn Tapaneeyakul.
Observations that peritoneal dialysis (PD) may be an effective, lower-cost alternative to hemodialysis for the treatment of ESKD have led to policies encouraging PD and subsequent increases in its use in the United States.
"The COVID-19 effect is likely to reduce the demand for public transport in favor of lower density alternatives," write the authors. Their study considers links between commuters' demographic factors and incidence of disease transmission, as well as the environmental implications of decreased ridership on public transport.
Kenneth B. Medlock III, Ted Loch-Temzelides, Shih Yu (Elsie) HungNovember 4, 2021
This study finds that Maryland's all-payer model for healthcare comparatively lowered the risk of complications from surgery, as well as reducing increases in associated costs.
Anaeze C. Offodile II, Oluseyi Aliu, Andrew W. P. Lee, Jonathan E. Efron, Robert S. D. Higgins, Charles ButlerSeptember 28, 2021
The authors found that six months of pre–end-stage kidney disease nephrology care did not significantly improve the likelihood that patients would remain employed when they started dialysis. This finding underscores the need to identify effective methods to help patients stay employed when they transition to dialysis.
Expanded “payment bundles” for the treatment of end stage kidney disease did not in general increase the risk of closure by dialysis facilities, the authors conclude.
Sayna Norouzi, Bo Zhao, Ahmed Awan, Wolfgang Winkelmayer, Vivian Ho, Kevin EricksonFebruary 5, 2020